CLS begins evaluation of new thermal therapy system

2021 07 13 16 11 0027 Prostate Cancer 400

Image-guided focal laser ablation technology developer Clinical Laserthermia Systems (CLS) said that its new Transberg thermal therapy system is now being evaluated for use in MRI/ultrasound fusion-guided focal laser ablation of prostate tumors.

In a 10-patient clinical trial, researchers at Germany's Otto von Guericke University Magdeburg are assessing Transberg's performance in providing fusion-guided focal laser ablation therapy for early-stage prostate cancer, according to the vendor.

Page 1 of 1247
Next Page